SATO FOODS INDUSTRIES CO., LTD.
2814・Standard Market・Foods
Business
Sato Foods Industries Co., Ltd., founded in 1954 and headquartered in Komaki City, Aichi Prefecture, is a specialist manufacturer of natural food ingredients. The company manufactures and sells products across five categories: tea extracts (approximately 47% of net sales), powdered natural seasonings (approximately 28%), plant extracts (approximately 13%), liquid natural seasonings (approximately 11%), and powdered sake (approximately 1%). Its major customers include beverage and food manufacturers and trading companies such as Ito En, Ltd. (15.1% of net sales), Ohsho Shoji Co., Ltd. (11.2%), and Mitsubishi Corporation Life Sciences Limited (10.4%), and the company operates a B2B food ingredient supply business. It operates on a standalone basis without any subsidiaries or affiliates, and is listed on the Standard Market of the Tokyo Stock Exchange.
Business Model
By fusing the "natural flavor powderization" technology accumulated since founding with extraction and drying equipment technology, the company manufactures high-value-added materials such as tea extracts and natural seasonings. While maintaining a stable supply system through a make-to-forecast production approach, it sells directly to beverage, confectionery, and food service manufacturers as well as trading companies. The company continues to invest ¥161 million in R&D expenses (2.4% of net sales), securing earnings by extending product life cycles through new product development and quality improvement.
Company Strengths
In 1964, the company introduced spray dryers and began research into powdering seasonings, and in 1966 achieved the world's first powdered alcohol. Since then, over more than 60 years, it has accumulated proprietary technology combining development, manufacturing, and equipment know-how. It has obtained FSSC22000, ISO9001, ISO14001, and Organic JAS certifications, externally demonstrating the high level of its quality control system.
As of the end of FY2026 (ending March 2026), the company held cash and cash equivalents of ¥8,443 million, exceeding the same period's net sales of ¥6,832 million. Total liabilities remained low at ¥2,701 million, and against total net assets of ¥20,202 million, the equity ratio is extremely high. This financial foundation, capable of responding to sudden funding needs, supports continued investment in capital expenditure and R&D.
The top three customers—Ito En (15.1%), Ohsho Shoji (11.2%), and Mitsubishi Corporation Life Sciences (10.4%)—account for approximately 37% of net sales. Sales to Ito En expanded 17.5% year on year, confirming deepening business with major beverage makers. Given the nature of BtoB ingredient supply, once adopted, transactions tend to lead to continuous business relationships.
ENVALITH's Perspective
Performance Trend
Revenue grew for five consecutive periods, from ¥5,644 million in FY2022 (ended March 2022) to ¥6,832 million in FY2026 (ending March 2026). In FY2026, all major product categories saw increased sales, led by tea extract, resulting in revenue of ¥6,832 million (up 7.4% year on year), operating profit of ¥758 million (up 12.7%), and net income of ¥736 million (up 23.5%), reaching the highest levels since FY2022 (ended March 2022). As an external factor, growing demand for beverage and confectionery applications driven by expanding inbound tourism demand contributed as a tailwind. Meanwhile, the full-year forecast for FY2027 (ending March 2027) anticipates a sharp deterioration in earnings, with revenue of ¥6,732 million (down 1.5% year on year) and operating profit of ¥373 million (down 50.8%), with changes in the cost structure set to be a key focus.
Growth Strategy
Strengthening the management foundation across three pillars: development of high value-added products, productivity improvement, and enhancement of the quality assurance system
The company is focusing on developing new products with clear uniqueness and competitive advantage by applying its proprietary "natural flavor powderization" technology, developed since its founding. R&D expenses for FY2026 (ending March 2026) were ¥161 million (2.4% of net sales). In anticipation of a shrinking domestic market, the company continues to pursue differentiation through the expansion of its high value-added product lineup.
Expenditures for the acquisition of property, plant and equipment in FY2026 (ending March 2026) totaled ¥328 million (up from ¥258 million in the previous fiscal year), and construction in progress also increased significantly to ¥296 million (from ¥64 million in the previous fiscal year), indicating accelerating capital investment. The company aims to reduce costs and build a stable supply system through the promotion of automation and labor-saving measures and the strengthening of its production framework.
As a company engaged in food production, the company positions the provision of safe and reliable products as its most important issue, and strives to further strengthen its production and quality assurance systems by securing appropriate personnel. The company maintains a policy of stable procurement while closely monitoring trends in raw material and energy costs, including tea leaf raw materials, its primary raw material.
In FY2026 (ending March 2026), the company conducted share buybacks totaling ¥830 million, with an annual dividend of ¥50 per share (payout ratio of 25.7%). For FY2027 (ending March 2027), the company plans to maintain an annual dividend of ¥50 per share, maintaining the dividend level even under a forecast of a substantial decline in profit. This demonstrates a stance of balancing efficient use of shareholders' equity with continuous profit distribution.
Last updated: July 19, 2026